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Abstract
Purpose To study the influence of xenotransplantation on
follicular recruitment and growth in cryopreserved/thawed
human ovarian tissue.
Method Two 3-mm pieces of cryopreserved/thawed human
ovarian tissue obtained from female cancer patients (n = 11)
were xenotransplanted into a subcutaneous neck pouch of 6-
week-old ovarectomized SCID mice (n = 33) for 4 (n = 18)
and 12 (n = 15) weeks.
Result Thirty-two out of 33 mice survived the entire observa-
tion periods. Graft recovery rate was 95.58 % (65 of 68 grafts).
The percentages of primordial follicles after 4 weeks
(P < 0.001) and 12 weeks (P = 0.009) of grafting were signifi-
cantly lower in comparison to pregraft controls. The percentage
of secondary follicle was significantly higher after 4 weeks of
grafting (P = 0.018) and after 12 weeks (P = 0.001) of grafting
in comparison to pregraft controls. Ki67 immunohistochemis-
try showed that proliferative follicles were significantly higher
after 4 and 12 weeks of grafting compared to pregraft controls
(P < 0.001). All follicles analyzed by TUNEL staining ap-
peared healthy after xenotransplantation. The expression
level of PTEN was reduced by 2.47-fold after 4 weeks of
Capsule The higher proportion of growing follicles compared to resting
follicles observed after xenotransplantation is most likely due to
downregulation of PTEN gene expression followed by acceleration of
follicular recruitment.
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xenotransplantation, and this result was significant when
2−ΔCt were analyzed (P = 0.042).
Conclusion The higher proportion of growing follicles com-
pared to resting follicles observed after xenotransplantation is
most likely due to downregulation of PTEN gene expression
followed by acceleration of follicular recruitment.
Keywords Fertility preservation . Human ovarian tissue
xenotransplantation . Human ovarian tissue
cryopreservation . Follicular recruitment . PTEN
Introduction
The numbers of long-term cancer survivors are steadily increas-
ing during the last decades leading to an actual 5-year survival
rate for children of 79 % [1]. Several factors such as early cancer
detection, advanced diagnostic tools, and aggressive cancer ther-
apies have been contributing to this improvement. Therefore, due
to the increasing life expectancy in cancer patients, the late side
effects caused by high dose chemotherapies and radiotherapies
are currently gaining more attention. One of the common and
serious long-term side effects related to cancer therapy in female
patients is premature ovarian failure (POF). Chemotherapeutic
agents and irradiation are known to induce POF through destruc-
tion of ovarian follicular reserve by different mechanisms de-
pending on the age of the patients, as well as on the type and
the dose of cytotoxic agents [2–6].
To overcome this problem, several multidisciplinary strat-
egies have been established to preserve female fertility [7–11].
One of the important developments in fertility preservation is
ovarian tissue cryopreservation and autotransplantation. This
method might be the only available method for prepubertal
girls. Furthermore, it can be offered to patients immediately
without delay in cancer therapy [9]. So far, there are more than
60 live births reported worldwide after autotransplantation of
cryopreserved/thawed human ovarian tissue [12–22]. Data
from three fertility preservation centers showed that endocrine
ovarian function can be restored in 93 % of patients after
autotransplantation [23]. Pregnancy rates after 111 cases of
ovarian tissue autotransplantation in 5 fertility preservation
centers were 29 % [24]. However, clinical data showed de-
creased ovarian reserve and low response to ovarian stimula-
tion in patients after ovarian tissue autotransplantation [25,
26]. This decreased ovarian reserve after transplantation was
proven by the low concentrations of anti-Mullerian hormone
(AMH) and inhibin B as well as high levels of follicle-
stimulating hormone (FSH) [25–27]. This indicates that fur-
ther studies are needed to improve the outcome of ovarian
tissue cryopreservation followed by autotransplantation.
One accepted experimental approach to evaluate function-
ality of cryopreserved human ovarian tissue is xenotransplan-
tation into severe combined immunodeficient (SCID) mice
[28]. Several studies showed a considerable decline in follic-
ular density and an increase of follicular growth after xeno-
transplantation [29–32]. However, the mechanisms behind this
rapid follicular recruitment and subsequent follicular loss after
xenotransplantation are still unclear. Especially molecules regu-
lating cell growth and organ size are currently being investigated
as published by Kawamura et al. [14]. Furthermore, Roness et al.
[33] hypothesized that the increase of follicular growth might be
caused by disruption of follicular growth regulation leading to
Bovarian follicle burnout.^ The same authors observed this phe-
nomenon in a mouse model, after administration of the
gonadotoxic agent cyclophosphamide as well as after xenotrans-
plantation of untreated bovine ovarian tissue [34, 35]. In addition
to that, Silber et al. [20] observed an Bover-recruitment^ of rest-
ing follicles after ovarian tissue transplantation indicated by the
increase of AMH to above normal levels in the recipient com-
pared to the donor.
One of the important pathways for maintenance of follicu-
lar dormancy is the phosphoinositide 3-kinase (PI3K)/phos-
phatase and tensin homolog deleted on chromosome 10
(PTEN)/protein kinase B (Akt) pathway [36–38]. PTEN has
been shown to be an important inhibitor of follicular growth
initiation [39]. Oocyte-specific deletion of PTEN in mice led
to over-activation of primordial follicles and subsequently to
POF [39, 40]. In addition, it has been shown that PTEN in-
hibitors can cause follicular activation of murine follicles
in vivo and of human follicles in vitro [41–43].
The aim of this study was to evaluate the mechanisms
involved in follicular recruitment after xenotransplantation
of human ovarian tissue in SCID mice and to investigate the
impact of transplantation on follicular growth and depletion.
Materials and methods
Ethical approval
The use of human ovarian tissue samples in this study was
approved by the Ethical Committee of the Medical University
of Innsbruck. The animal experimentation in this study was
performed under the approval from the Federal Ministry of
Science and Research of Austria.
Human ovarian tissue
Human ovarian tissue samples used in this study were obtain-
ed from 11 cancer patients with informed consent. The age of
the patients at the time of ovarian tissue cryopreservation
ranged from 20 to 39 years (mean age 27.0 years). AMH
was determined with a commercially available ELISA kit
(AMH Gen II ELISA, Beckman Coulter, Germany) before
laparoscopic retrieval of ovarian tissue in all patients except
one. Patient characteristics are presented in Table 1.
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Animals
Female CB17/lcrHanHsd SCID mice were purchased from
Harlan Laboratories, Italy, and delivered at 5 weeks of age.
They were housed in a temperature- and light-controlled en-
vironment (22 °C and 12-h light/12-h dark) in individually
ventilated cages (IVC) with high-efficiency particulate air fil-
ters, at the animal care facility of the Medical University of
Innsbruck. Animals were supplied with water and food ad
libidum, and a maximum of six animals were housed per cage.
Animals were allowed to acclimatize for 1 week.
All of the procedures related to the animals were performed
under a laminar flow-hood. Thirty-three 6-week-old mice
were used in this study. Five independent repeats of the com-
plete experiment were carried out.
Collection of human ovarian tissue
Human ovarian tissue samples were laparoscopically retrieved
and transferred to the laboratory of the Department of
Gynecological Endocrinology and Reproductive Medicine,
Medical University of Innsbruck, in Leibovitz medium
(L-15, Invitrogen, Germany) within a 50-ml polystyrene con-
ical tube (BD Falcon, BD Biosciences, Austria).
Human ovarian tissue cryopreservation
Cortical strips from human ovarian tissue samples (~10 × 5 ×
2 mm) were prepared under sterile conditions in Leibovitz
medium. The cryopreservation procedure was performed
using a slow-freezing protocol. Ovarian tissue samples were
transferred to 2.0 ml cryovials (Nunc, Germany) containing
1.7 ml of cryopreservation medium (OvarStore, Gynemed,
Germany) and placed into an automated, computer-controlled
freezing system (IceCube 14S, Sy-Lab, Austria). The initial
cooling rate was −2 °C/min to −7 °C. At this temperature,
manual seeding was performed. After keeping the tissue for
10 min at this temperature, cooling was continued at the rate
of −0.3 °C /min until −65 °C for approximately 220 min. Then
cryovials were plunged into liquid nitrogen for storage.
Human ovarian tissue thawing and preparation
Under aseptic conditions, cryovials were placed at room tem-
perature for 30 s, and then transferred to a 37 °Cwater bath for
130 s. Afterwards, the tissue samples were washed stepwise in
medium containing DPBS (Sigma–Aldrich, Austria), genta-
micin (Sigma–Aldrich, Austria), serum substitute supple-
ments (Irvine Scientific, Austria), and decreasing sucrose con-
centrations (MP Biomedicals, Austria). The last washing step
was performed in G-MOPS plus medium (Vitrolife, Austria).
Thawed cortical strips were then dissected into 3-mm biopsies
using standardized biopsy punches and immediately
transported to the animal facility of the Medical University
of Innsbruck within 50-ml falcon tubes containing 5 ml pre-
warmed G-MOPS medium at 37 °C.
Xenotransplantation procedure
Mice were anesthetized with 0.1 mg/g body weight ketamine
hydrochloride (Ketasol, Gräub, Ogris Pharma, Austria) and
0.015 mg/g body weight of xylazine (Xylasol, Ani Medica
Ogris Pharma, Austria) intraperitoneally [44]. The average
body weight was 16.66 g and ranged from 14.50 to 18.40 g.
The surgery was performed on a 37 °C warming plate for
animal surgery (Vettech, UK). The eyes of the mice were
Table 1 Patients’ characteristics








1 Morbus Hodgkin 26 1.06 N
2 Breast Cancer 33 2.66 N
3 Morbus Hodgkin 22 Not applicablea N
4 Breast cancer 33 0.86 N
5 Breast cancer 27 2.14 N
6 Morbus Hodgkin 27 1.62 Y
7 Breast Cancer 39 <0.17 N
8 ALL 20 2.66 Y
9 B-NHL 22 0.33 Y
10 AML 23 <0.17 Y
11 NHL 25 2.70 N
In 10 out of 11 patients, AMH levels were measured before the laparoscopical retrieval of ovarian tissue for
cryopreservation. Seven patients did not receive chemotherapy before ovarian tissue cryopreservation and four
patients received chemotherapy before ovarian tissue cryopreservation. In one patienta , AMH level (<0.17 μg/l)
was determined after the surgery and after the first cycle of chemotherapy
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protected with an eye protection gel (Siccaforte, Agepha
Pharmaceutical, Austria). Bilateral ovarectomy was per-
formed via a dorsomedian incision. Excised mouse ovaries
were examined under a stereomicroscope (MZ6, Leica,
Austria) to ensure complete ovarectomy. After ovarectomy,
two 3-mm thawed human ovarian tissue pieces were
xenotransplanted into a subcutaneous neck-pouch and the
grafts were fixed with two 6/0 nylon sutures (Prolene,
Ethicon, Johnson & Johnson Medical Company, Austria).
The peritoneum and skin incisions were closed with a 6/0
nylon suture. Post-operative analgesia was assured by adding
25 μg tramadol (Tramabene, Ratiopharm, Germany) per mil-
liliter of drinking water. After grafting, the SCID mice were
randomized to be observed for either for 4 (n = 18) or 12 (n =
15) weeks. At the end of each observation period, the animals
were sacrificed. The grafts were recovered and immediately
fixed in 3.6 % formalin. Ovarian tissue samples directly after
thawing served as pregraft controls.
All procedures were carried out under a laminar flow hood
in order to maintain sterile conditions.
Follicle counting
Grafts were fixed in formalin and embedded in paraffin for
histological assessment. The paraffin blocks were cut into
serial sections of 3–5 μm. Every 12th section was stained with
Hematoxylin and Eosin (H&E) for follicle classification and
counting [45]. The sections in between were used for immu-
nohistochemistry and RNA isolation. Follicular development
was assessed by evaluating the follicular stages using a light
microscope (BX 40; Olympus, Germany) as described by
Myers et al. [46]. Briefly, a primordial follicle was defined
by an oocyte surrounded by one layer of flattened
pregranulosa cells, a primary follicle by an oocyte surrounded
by one layer of cuboidal granulosa cells, and a secondary
follicle by two or more layers of granulosa cells. An antral
follicle was defined by antrum formation. In the case of inter-
mediate stages between primordial and primary follicles,
those follicles showing at least one cuboidal granulosa cell
were classified as primary follicles. Only follicles with a vis-
ible nucleus in the oocyte were counted [47].
Follicular proliferation
Follicular proliferation was immunohistochemically evaluated
by the detection of the expression of the Ki67-protein in granu-
losa cells. Ki67 is expressed during proliferative cell phases (G1,
S, G2, and mitosis), but not during the resting cell phase (G0).
Ki67 immunostaining was performed within an automated
slide staining system (Benchmark Ultra, Ventana, USA) using
a primarymonoclonal rabbit antibody raised against humanKi67
(CONFIRManti-Ki67, Ventana, RocheGmbH,USA), a second-
ary goat anti- rabbit antibody (HRP system, Ventana, Roche
GmbH, USA), and the 3,3-diaminobenzidine tetrahydrochloride
(DAB) chromogen (ultraView DAB detection Kit, Ventana,
Roche GmbH, USA). Nuclei were counterstained with hematox-
ylin. Human breast carcinoma tissuewas used as positive control.
Only sections where follicles were detected in the adjacent H&E-
stained sections were analyzed.
Follicles with at least one granulosa cell stained positive
with Ki67 were considered to be proliferative follicles [48].
Follicular apoptosis
To analyze apoptosis after xenotransplantation, terminal
deoxynucleotidyl transferase-mediated dUTP nick end labeling
(TUNEL) assay (DeadEndTM Colorimetric TUNEL System,
Promega, Austria) was performed according to the manufac-
turer’s instructions, with 3,3-diaminobenzidine tetrahydrochlo-
ride (DAB) as chromogen. Mayer’s hemalaun solution (Merck
Millipore, Germany) was used for counterstaining. Only sections
where follicles were detected in the adjacent H&E-stained sec-
tions were analyzed. The TUNEL staining results were evaluated
by three independent observers.
Follicles consisting of ≥49 % TUNEL positive granulosa
cells as well as follicles containing a TUNEL positive oocyte
were classified as atretic follicles [49]. Sections without trans-
ferase enzyme and human lymph node sections treated with
DNAse served as negative and positive control, respectively.
PI3K pathway analysis
PTEN gene expression
Total ribonucleic acid (RNA) was isolated from 19 grafts bear-
ing follicles obtained from 8 patients. Twenty sections per par-
affin blockwere used for RNA isolationwith RNEasy FFPE kit
according to manufacturer’s protocol (Qiagen, Germany).
DNA digestion was performed using RNAse free DNAse
(Promega, Austria).
RNA concentration was measured either with UV-
spectrophotometer (GeneQuant 1300 Spectrophotometer,
GE Healthcare, Austria) or with a fluorescence staining kit
(Quant-iT Ribogreen RNA reagent, Life Technologies,
Germany). RNAwas stored at −80 °C. Reverse transcription
was performed with 50 ng of isolated RNA using the
Omniscript reverse transcriptase (Qiagen, Germany) and ran-
dom hexanucleotide primer (Carl Roth, Austria). Quantitative
PCR (qPCR) was performed using the Maxima SyBr Green/
ROX qPCR master mix (Thermo Scientific, Austria). The
following primers were used: PTEN (forward: PTEN, 5′-
TGACAATCATGTTGCAGCAATTC-3′, reverse: 5′-CACC
AGTTCGTCCCTTTCCA-3′) as the target gene [50]. Actin
(forward: 5′-ACT GGG ACG ACA TGG AGA AG-3′, re-
verse: 5′-GGG GTG TTG AAG GTC TCA AA-3′) was used
as housekeeping gene.
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qPCR was performed in 96-well plates (Peqlab, Austria)
using a BioRad iCycler (BioRad, Austria). The PCR profile
was started with an initial incubation at 95 °C for 10 s, follow-
ed by 40 cycles with denaturation at 95 °C for 5 s, and anneal-
ing and extension at 60 °C for 45 s. All qPCR measurements
were performed in triplicates and samples without reverse
transcriptase served as a negative control.
qPCR data were analyzed with iQ5 software (BioRad,
Austria), and the efficiency of each qPCR run was evaluated
with LinRegPCR data analysis program (version 2013.1;
http://LinRegPCR.nl) [51, 52].
PTEN gene expression level was calculated by subtracting the
actin CT values from PTEN CT values (ΔCt). Relative quanti-
tative analysis of PTEN gene expression was carried out using
the ΔΔCt method [53]. Fold change difference of PTEN ex-
pression was determined as 2−(ΔCt 4 weeks–ΔCt pregraft).
PTEN immunohistochemistry
To analyze the protein expression of PTEN, immunohisto-
chemistry was performed. Formalin-fixed and paraffin-
embedded tissue were cut into 3–5-μm-thin sections and heat-
ed for 20 min at 70 °C. PTEN immunostaining was performed
within an automated slide staining system (Benchmark Ultra,
Ventana, USA) with a primary monoclonal rabbit anti-PTEN
antibody (Clone D4.3, 1:250, Cell Signaling, USA), a second-
ary goat anti- rabbit antibody (HRP system, Ventana, Roche
GmbH, USA), and the DAB chromogen (ultraView DAB
detection Kit, Ventana, Roche GmbH, USA). Nuclei were
counterstained with hematoxylin. Human colon tissue was
used as positive control and sections stained without any pri-
mary antibody was used as negative control.
Statistics
Statistical analysis was performed using the SPSS software
package (version 20; SPSS, Inc., USA). All data are represent-
ed as mean ± SEM. The nonparametric Mann–Whitney U test
was performed to compare follicle counts. A paired-sample t
test was performed to compare PTEN gene expression.
Immunohistochemical results from Ki67 were analyzed with
chi-square test. Statistical significance was confirmed by P
values <0.05.
Results
Macroscopic evaluation of the grafts
Thirty-two of 33 mice (96.97 %) survived throughout the whole
observation period. Sixty-five out of 68 grafts (95.58 %) were
successfully recovered from all groups. Two grafts showed a
macroscopically visible antral cavity after 12 weeks of grafting.
Rapid follicular recruitment after xenotransplantation
of cryopreserved/thawed human ovarian tissue
Follicle counting
A total of 1014 follicles were counted within 58 biopsies.
Twenty-six biopsies did not contain any follicles and were
excluded from further calculations. Pregraft controls (n = 17)
contained 669 follicles, 4-week grafts (n = 24) contained 183
follicles, and 12-week grafts (n = 17) contained 162 follicles.
The percentage of primordial follicles after 4 weeks of
grafting (38.95 ± 3.94 %) was significantly lower in compar-
ison to pregraft controls (72.88 ± 5.93 %, P < 0.001). The per-
centage of primordial follicles after 12 weeks of grafting
(37.42 ± 5.83 %) was also significantly lower (P = 0.009)
compared to pregraft controls. The percentage of primary fol-
licles was also significantly different after 4 weeks (29.29 ±
2.60 %, P = 0.009) compared to pregraft controls (13.48 ±
2.92 %). However, the percentage of primary follicles was
not significantly different after 12 weeks of grafting (9.74 %
± 2.22 %) compared to pregraft control (P = 0.259). The per-
centage of secondary follicles was significantly increased after
4 weeks (27.60 ± 4.16 %, P = 0.018) and 12 weeks (49.40 ±
6.14 %, P = 0.001) of grafting compared to pregraft controls
(13.37 ± 6.09 %). There were two antral follicles observed in
the pregraft control, one after 4 weeks of grafting, and two
after 12 weeks of grafting. There was a significant difference
in the percentage of primary follicles (P = 0.001) between the
two observation periods after grafting (Fig. 1).
Fig. 1 Follicles were classified and counted in pregraft control, 4-week
grafts, and 12-week grafts. Total follicles per biopsy as well as
percentages of primordial, primary, and secondary follicles are presented
in mean ± SEM. Antral follicles are not represented in the figure and the
table because they formed only 0.49 % (5/1014) of all follicles observed.
a Significant differences between the two observation periods and
pregraft control (P < 0.05). b Significant differences between 4 and
12 weeks of grafting (P < 0.05)
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Follicular growth
A total of 196 follicles from 10 patients were analyzed for Ki67
immunohistochemistry. The percentage of all Ki67-positive fol-
licles after 4 (70.59 %, P < 0.001) and 12 (81.82 %, P < 0.001)
weeks of grafting was significantly higher compared to pregraft
controls (11.02 %). The percentage of Ki67-positive primordial
follicles increased from 10.28 % in pregraft controls to 70.83 %
after 4 weeks of grafting (P < 0.001) and to 70.59 % after
12 weeks of grafting (P < 0.001). The percentage of Ki67 posi-
tive primary follicleswas not significantly higher after 4weeks of
grafting (50 %, P = 0.205) compared to pregraft controls
(18.18 %), but it was significantly higher after 12 weeks of
grafting (72.73 %, P = 0.015) compared to pregraft controls
(18.18 %). All detected secondary follicles were Ki67-positive
regardless of the observation period. Two antral follicles were
found after 12 weeks of grafting and both were Ki67 positive.
There was no significant difference in the percentage of Ki67
positive follicles of all stages between 4 and 12 weeks of grafting
(Table 2 and supplementary Fig. 2).
Follicular apoptosis
In order to detect signs of apoptosis, 96 follicles from 9 pa-
tients were analyzed. In pregraft controls and after 4 weeks of
grafting, none of the follicles were TUNEL positive. After
12 weeks of grafting, one secondary follicle showed one
TUNEL-positive granulosa cell (supplementary Fig. 3).
Downregulation of PTEN expression
after xenotransplantation of cryopreserved/thawed
human ovarian tissue
PTEN gene expression
PTEN expression was analyzed in 8 pregraft controls and 11 4-
week-grafts obtained from 8 patients. Genomic DNA contami-
nation was negative in all RNA samples. The relative gene ex-
pression of PTEN was compared between pregraft controls and
4-week grafts after normalization using actin as the housekeeping
gene. The amplification efficiency of qPCR was higher than 1.8
in all measurements. The expression of PTEN was reduced by
2.47-fold after 4 weeks of xenotransplantation (Fig. 2). This re-
sult was significant when 2−ΔCt were analyzed (P = 0.042).
There was no significant correlation between the reduced num-
bers of follicles and PTEN expression as shown in supplemen-
tary data (supplementary Fig. 5).
Table 2 Percentage of Ki67 positive follicles in pregraft controls, 4-
week grafts, and 12-week grafts
Follicle stage Pregraft 4 weeks 12 weeks
Primordial 10.28 % 70.83 %a 70.59 %a
(11/107) (17/24) (12/17)
Primary 18.18 % 50 % 72.73 %a
(2/11) (3/6) (8/11)
Secondary – 100 % 100 %
– (4/4) (14/14)
Antral – – 100 %
– – (2/2)
Total Ki67 positive follicles 11.02 % 70.59 %a 81.82 %a
(13/118) (24/34) (36/44)
Percentage of primordial, primary, secondary, and antral follicles showing
Ki67 immunostaining in pregraft controls and after 4 and 12 weeks of
grafting, respectively. The total number of Ki67-positive follicles as well
as the total number of all analyzed follicles are given in brackets
a Significant difference between the two observation periods compared to
the pregraft control (P < 0.05)
Fig. 2 Relative expression of the
PTEN gene after
xenotransplantation compared to
pregraft control. Figure shows
2.47-fold reduction of the PTEN
gene expression after 4 weeks of
grafting. This difference reached
significance when 2−ΔCt were
analyzed. Data are presented in
mean ± SEM
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PTEN immunohistochemistry
PTEN protein expression was detectable in theca cells and
granulosa cells from growing follicles, as well as in the nuclei
and cytoplasm of all oocytes (supplementary Fig. 6). In gran-
ulosa cells of primordial follicles, PTEN protein was either
absent or weakly expressed.
Discussion
This study examines for the first time the molecular mechanisms
that may be involved in the increased follicular recruitment after
xenotransplantation of cryopreserved/thawed human ovarian tis-
sue. The data, compiled from a considerable number of patients,
show that the observed acceleration of follicular growth is most
likely due to downregulation of PTEN.
After 4 and 12 weeks of grafting, histological evaluation re-
vealed a pronounced decrease of primordial follicles accompa-
nied by an increase of growing follicles. Only few granulosa cells
and none of the oocytes were apoptotic after grafting. In addition,
increased follicular recruitment was indicated by the increase of
Ki-67-positive primordial and primary follicles after 4 and
12 weeks of xenotransplantation.
A corresponding downregulation of PTEN was detected with
qPCR after grafting, without any significant correlation between
the reduced numbers of follicles and PTEN expression as shown
in supplementary data (supplementary Fig. 5).
PTEN is an important component of the PI3K pathway,which
has been described to play a crucial role in follicular recruitment
[36]. The deletion of PTEN in mice has been shown to result in
premature ovarian failure due to the complete depletion of pri-
mordial follicles [39]. In vitro culture studies in human ovarian
tissue by Novella-Maestre et al. [54] showed that PTEN inhibi-
tion enhances the activation of primordial follicles and increases
the population of growing follicles without inducing apoptosis in
follicles or in the surrounding stroma. Other in vitro studies by
McLaughlin et al. [42] demonstrated that the addition of the
PTEN inhibitor bpV(HOpic) alters human ovarian follicular
growth by inducing the initiation of primordial follicle recruit-
ment to the secondary stage. Additionally, Li et al. [43] proved
that the administration of a PTEN inhibitor bpV(HOpic) and a
PI3K-activating peptide 740Y-P to ovarian tissue could promote
follicular development and oocyte maturation.
This ovarian follicle Bburnout^ caused by dysregulation of the
PI3K pathway might be a universal phenomenon [33]. Kalich-
Philosoph et al. demonstrated the accelerated growth of primor-
dial follicles within 24 h after cyclophosphamide administration
in rodents [34]. In accordance with our study, this was not due to
apoptosis, but to activation of the PI3K pathway [34].
Additionally, Silber et al. [20] also observed amassive recruit-
ment of resting follicles after transplantation of cryopreserved/
thawed ovarian tissue shown by increased AMH levels.
Moreover, Silber et al. [55] hypothesized that resting follicles
could undergo recruitment after an ovarian tissue fragmentation
due to the release from the dense ovarian cortex, which physio-
logically might arrest follicle recruitment [55–57]. In addition,
other studies showed that fragmentation of human ovarian tissue
and incubation with Akt stimulators leads to the activation of
dormant follicles in patients suffering from premature ovarian
insufficiency [14, 19].
In conclusion, to our knowledge, our study confirms these
results for the first time in vivo using human ovarian tissue from
cancer patients in a xenotransplantation model. Certainly, further
studies including shorter observation periods are needed in order
to evaluate the starting point of follicular recruitment after
xenotransplantation.
In addition, it is essential to investigate additional genes in-
volved in the PI3K pathway, such as Akt, FOXO 3a, and mTOR
in human ovarian tissue xenotransplantation. Furthermore, differ-
ent graft sizes should be evaluated according to previous findings
in bovine ovarian tissue.
Overall, the findings of this study might help improve post-
transplantational outcomes, as loss of primordial follicles impairs
longevity of the grafts after transplantation.
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